Federal Data Hub › HRSA 340B · JSON
340B ID HM462601
ParticipatingHemophilia Treatment Center
INDIANA HEMOPHILIA AND THROMBOSIS CENTER is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in Indianapolis, IN. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 7 contract-pharmacy arrangement(s) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| ACCREDO HEALTH GROUP INC | WARRENDALE, PA | 2025-07-01 | — | 23041 |
| ACCREDO HEALTH GROUP INC | MEMPHIS, TN | 2025-07-01 | — | 45979 |
| ACCREDO HEALTH GROUP, INC. | ORLANDO, FL | 2025-07-01 | — | 39194 |
| ACCREDO HEALTH GROUP, INC. | WHITESTOWN, IN | 2025-07-01 | — | 133193 |
| ACCREDO HEALTH GROUP, INC. | LENEXA, KS | 2025-07-01 | — | 62883 |
| OPTUM INFUSION SERVICES 550, LLC | CINCINNATI, OH | 2026-04-01 | — | 50817 |
| POSITUDES INC | WESTBURY, NY | 2022-07-01 | — | 8621 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.